ApprovalTrail

Ingredient

Valproic Acid

Products in Health Canada’s databases that list Valproic Acid as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.

Also listed as “Valproic Acid (Sodium Valproate)” (12). How names are joined

Drug products
33
10 authorized now
Natural health products
0
0 active licences
Notices of Compliance
78
Products in all
33

Drug products

Authorized products first.

NameDINStatus
APO-VALPROIC ACID (250 MG)Apotex Inc. · Status since Aug 202102238048Marketed
DEPAKENE (250 MG)BGP Pharma ULC · Status since Sep 201600443832Marketed
JAMP VALPROIC ACID ORAL SOLUTION (250 MG)JAMP Pharma Corporation · Status since Oct 202302532441Marketed
ODAN-VALPROIC ACID (250 MG)Odan Laboratoriesltd · Status since Nov 202402549190Marketed
PMS-VALPROIC ACID (250 MG)Pharmascience Inc. · Status since Feb 199702230768Marketed
PMS-VALPROIC ACID (250 MG)Pharmascience Inc. · Status since Nov 199702236807Marketed
APO-VALPROIC ACID ORAL SOLUTION (250 MG)Apotex Inc. · Status since Oct 202402238370Dormant
PMS-VALPROIC ACID E.C. (500 MG)Pharmascience Inc. · Status since Jul 202602229628Dormant
VALPROIC ACID (250 MG)Apotex Inc. · Status since Nov 202002237830Approved
VALPROIC ACID ORAL SOLUTION (250 MG)Apotex Inc. · Status since Nov 202002238069Approved
DEPAKENE (250 MG)BGP Pharma ULC · Status since May 201700443840Cancelled Post Market
DEPAKENE CAP 500MG (500 MG)Abbott Laboratories Co. · Status since May 200700507989Cancelled Post Market
DEPROIC SYRUP (250 MG)Technilab Pharma Inc. · Status since Jul 200602238042Cancelled Post Market
DOM-VALPROIC ACID (250 MG)Dominion Pharmacal · Status since May 202502231030Cancelled Post Market
DOM-VALPROIC ACID (250 MG)Dominion Pharmacal · Status since May 202502238817Cancelled Post Market
DOM-VALPROIC ACID E.C. (500 MG)Dominion Pharmacal · Status since May 202502231031Cancelled Post Market
EPIJECT I.V. (500 MG)Abbott Laboratories Co. · Status since Oct 200702238368Cancelled Post Market
FTP-VALPROIC ACID (250 MG)Ftp-Pharmacal Inc. · Status since Aug 200402238448Cancelled Post Market
MYLAN-VALPROIC (250 MG)Mylan Pharmaceuticals Ulc · Status since Jun 201602184648Cancelled Post Market
NOVO-VALPROIC (250 MG)Teva Canada Limited · Status since May 201802100630Cancelled Post Market
NOVO-VALPROIC (500 MG)Teva Canada Limited · Status since May 201802218321Cancelled Post Market
PENTA-VALPROIC CAPSULES (250 MG)Pentapharm Ltd. · Status since Apr 201802231248Cancelled (Unreturned Annual)
PHL-VALPROIC ACID (250 MG)Pharmel Inc. · Status since Jan 201202238210Cancelled Post Market
PHL-VALPROIC ACID (250 MG)Pharmel Inc. · Status since Oct 201602260654Cancelled Post Market
PHL-VALPROIC ACID E.C. (500 MG)Pharmel Inc. · Status since Oct 201602260662Cancelled Post Market
RATIO-VALPROIC (250 MG)Teva Canada Limited · Status since May 201802217414Cancelled Post Market
RATIO-VALPROIC (500 MG)Teva Canada Limited · Status since May 201802231489Cancelled Post Market
RATIO-VALPROIC - ECC 500MG (500 MG)Ratiopharm Inc Division Of Teva Canada Limited · Status since Aug 201002140055Cancelled Post Market
RATIO-VALPROIC 50MG/ML SYRUP (50 MG)Ratiopharm Inc Division Of Teva Canada Limited · Status since Oct 201502140063Cancelled Post Market
RATIO-VALPROIC-CAP 250MG (250 MG)Ratiopharm Inc Division Of Teva Canada Limited · Status since Sep 201402140047Cancelled Post Market
SANDOZ VALPROIC (500 MG)Sandoz Canada Inc. · Status since Aug 200802239713Cancelled Post Market
SANDOZ VALPROIC (250 MG)Sandoz Canada Inc. · Status since Aug 201902239714Cancelled Post Market
VALPROIC-250 (250 MG)Pro Doc Limitee · Status since Jul 201202238546Cancelled Post Market

Notices of Compliance

Approvals of drug submissions that list it, newest first.